Ventyx Biosciences
www.ventyxbio.comWe are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.
Read more
We are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.
Read more
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President , Regulatory Affairs
Email ****** @****.comPhone (***) ****-****Executive Director , Program Management
Email ****** @****.comPhone (***) ****-****Board Member and Audit Committee Chair
Email ****** @****.comPhone (***) ****-****President and Chief Medical Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(11)
Reach decision makers at Ventyx Biosciences
Free credits every month!
Ventyx Biosciences FAQ
United States
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
